...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Toxicity
5
Nov 02, 2022 03:10PM

 Actually, they are both just suspended at this time although the one appears a lot more likely to be discontinued then the other.

3
Nov 02, 2022 03:51PM
2
Nov 02, 2022 03:53PM
3
Nov 02, 2022 04:19PM
1
Nov 02, 2022 04:59PM
3
Nov 02, 2022 09:26PM
6
Nov 03, 2022 03:28PM
4
Nov 03, 2022 04:08PM
2
Nov 03, 2022 04:50PM
4
Mar 22, 2023 03:44PM
5
Mar 24, 2023 02:30PM
5
Mar 26, 2023 10:12AM
Share
New Message
Please login to post a reply